NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-07-23
Reading OLPX? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround situation, as OLPX is currently loss-making and facing management volatility. The thesis is in a cautious state, given the recent weak financial performance and sector headwinds.
The market appears to be pricing in a low level of confidence, as indicated by the low expectations gap and the company's fragile valuation. The current pricing reflects a turbulent sector backdrop rather than a full premium for its weaknesses.
Fundamentals may remain weak in the near term due to ongoing losses and a history of earnings misses. However, recent changes show a slight improvement in company momentum, which could offer some support.
The thesis hinges on the performance of sector bellwethers like WSM, ULTA, and DKS. If these companies continue to perform well, it could provide a tailwind for OLPX, but any negative guidance from them could further pressure OLPX.
In the next 1 to 3 years, OLPX faces significant challenges but also potential opportunities depending on sector dynamics. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Gross margin is key for making money. Stability shows good cost control.
Confirms:Adjusted gross margin for Q2 2026 stays within the guided range of 71% to 72%.
Disproves:Adjusted gross margin for Q2 2026 drops below 71%.
Why it matters: Management has set a revenue target of $414 million to $435 million for 2026. Meeting this target shows stability in sales.
Confirms:Q2 2026 revenue reported at or above $105 million.
Disproves:Q2 2026 revenue reported below $100 million.
Why it matters: The court's decision on the settlement will affect Olaplex's rules and shareholder rights. It may also change how investors feel about the company after the merger.
Confirms one read:The court approves the settlement. This confirms the governance changes and dismisses the claims.
Confirms the other:The court rejects the settlement. This allows the claims to continue and may lead to more lawsuits.
Why it matters: Management's revenue guidance is a key indicator of growth. It shows how well the company is doing.
Confirms one read:Management says 2026 revenue will be between $414 million and $435 million.
Confirms the other:Management lowers 2026 revenue guidance from the current range.
Why it matters: If revenue grows, it means more people want Olaplex products.
Confirms:Q2 revenue growth reported as positive year over year.
Disproves:Q2 revenue growth reported as negative year over year.
Why it matters: Operating margin shows how well the company controls costs. It's key to long-term growth.
Confirms one read:Operating margin gets better to -$4 million or more in Q2 2026.
Confirms the other:Operating margin worsens to -$6 million or worse in Q2 2026.
